StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report report published on Saturday. The brokerage issued a sell rating on the stock.
Separately, HC Wainwright raised their price target on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research report on Thursday, December 12th.
View Our Latest Stock Analysis on SenesTech
SenesTech Price Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- Best Stocks Under $5.00
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- The 3 Best Fintech Stocks to Buy Now
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Ride Out The Recession With These Dividend KingsĀ
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.